17.4 C
New York
Tuesday, June 9, 2026

Tag: body

AscellaHealth Establishes International Strategic Advisory Council, Enhances Global Life Sciences Support Services Amid Regulatory and Market Complexity

AscellaHealth Establishes International Strategic Advisory Council, Enhances Global Life Sciences Support Services Amid Regulatory and Market Complexity

P2 Gold Gabbs Project Update: Feasibility Study on Track

VANCOUVER, BC, June 9, 2026 /CNW/ - P2 Gold Inc. ("P2" or the "Company") (TSXV: PGLD) (OTCQB: PGLDF) provides an update on the activities underway...

atNorth Joins Norwegian Data Center Industry (Norsk Datasenterindustri) Following Strategic Expansion into Norway

Membership reinforces commitment to sustainable growth, regional collaboration, and sovereign digital infrastructure in the NordicsREYKJAVÍK, Iceland, June 9, 2026 /PRNewswire/ -- atNorth, the leading...

Beauty of Joseon Named ‘Global No.1 K-Beauty Suncare Brand in Online Sales’ by Euromonitor International

SEOUL, South Korea, June 9, 2026 /PRNewswire/ -- Beauty of Joseon has been recognized by global market intelligence company Euromonitor International as the "Global No.1...

Beauty of Joseon Named ‘Global No.1 K-Beauty Suncare Brand in Online Sales’ by Euromonitor International

SEOUL, South Korea, June 9, 2026 /PRNewswire/ -- Beauty of Joseon has been recognized by global market intelligence company Euromonitor International as the "Global No.1...

Zepp Health Corporation Reports First Quarter of 2026 Unaudited Financial Results

MILPITAS, Calif., June 8, 2026 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today announced its unaudited financial results for the...

Ascendis to Showcase Advances in Treatment of Rare Endocrine Diseases at ENDO 2026

COPENHAGEN, Denmark, June 08, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from its Endocrinology Rare Disease programs in hypoparathyroidism, achondroplasia, and pediatric growth hormone deficiency will be shared in two oral presentations and three posters at ENDO 2026, the annual meeting of the Endocrine Society being held in Chicago from June 13-16, 2026.

D1 Training Named a Top 10 Fitness Franchise in Entrepreneur’s New 2026 Industry Rankings

Athletic-Based Training Brand Earns No. 10 Spot Among the Nation's Leading Fitness Franchises in Entrepreneur's Inaugural Industry-Specific RankingNASHVILLE, Tenn., June 8, 2026 /PRNewswire/ --...

/C O R R E C T I O N — PEET’S COFFEE INC./

In the news release, PEET'S COFFEE LAUNCHES NATIONWIDE SEARCH FOR ITS FIRST-EVER "CHIEF PLAYLIST OFFICER" TO BEAT AMERICA'S 3PM SLUMP, issued 03-Jun-2026 by PEET'S...

AG1 LAUNCHES AG1 PRO WITH CREATINE AND MORE FOR ADVANCED MUSCLE AND GUT SUPPORT

AG1 Pro's advanced formula builds on AG1's clinically-backed formula to include additional research-backed key ingredients, including creatine, that target muscle strength, metabolic resilience, and...

National Kidney Foundation and U.S. Pharmacy Organizations Call for Transition to Race-Agnostic eGFR in Medication Decision-Making

NEW YORK, June 8, 2026 /PRNewswire/ -- A coalition of leading U.S. pharmacy organizations, in collaboration with the National Kidney Foundation (NKF), is urging...

Behind CISCE with Jason: Inside a hardcore automobile manufacturer and its supplier network

BEIJING, June 8, 2026 /PRNewswire/ -- This is a report from China.org.cn Video Link: China International Supply Chain Expo, or CISCE, showcases not only...

Foresee’s Oral ALDH2 Activator, Mirivadelgat to Enter Clinical Testing in Parkinson’s Disease in the SLEIPNIR Phase 2a Platform Trial

TAIPEI, June 8, 2026 /PRNewswire/ -- Foresee Pharmaceuticals (6576.TWO), ("Foresee") announced today that Foresee's oral ALDH2 activator, mirivadelgat, has been selected to enter clinical testing in...

Ascletis Reinforces Its Differentiated Obesity Portfolio at American Diabetes Association (ADA) 2026 Scientific Sessions, Showcasing ASC30 Clinical Data and Exciting Preclinical Findings from ASC37...

HONG KONG, June 7, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces the presentation of three key studies at the American Diabetes...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsBody